Computer-aided systems for melanoma - The objectives of this project are to develop automated computer systems to help interpret complex dermoscopic images with the ultimate aim of distributing the technique to non-dermatologist healthcare providers and, maybe, even patients.
The PACER lab leads the health economics activities of this multi-year research project in collaboration with researchers from the Genome Sciences Centre and the Centre for Lymphoid Cancer.
The Silent Genomes project aims to elucidate and address the health inequities faced by Canadian Indigenous populations when accessing genomic technologies for the diagnosis of genetic diseases.
The GeneSolve study, recently funded by Genome British Columbia, examines the value of genomic sequencing for diagnosing childhood rare diseases.
BC Cancer’s Personalized OncoGenomics (POG) Program is a world-leading initiative applying whole-genome and transcriptome analysis (WGTA) to inform real-time treatment decisions for patients with advanced, hard-to-treat cancers. Using a mixed methods approach, Dr.
In 2017, with funding from CIHR’s Partnership for Health Systems Improvement initiative, we established the Canadian Real-World Evidence for Value of Cancer Drug (CanREValue) project team.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.